RADIFY AI

RADIFY AI is a web-based AI medical imaging tool for radiologists, public hospitals, and private practices that assists with detecting and triaging abnormalities on chest X-rays, including TB and pneumonia-related findings.

Key capabilities include:

• Chest X-ray abnormality detection for 16 to 20 major abnormalities, including TB-associated patterns and pneumonia-related pathologies (such as consolidations, infiltrates, and lymphadenopathy)
• High-throughput triage that can label and prioritise over 2000 X-rays per minute, helping teams manage imaging backlogs in high-volume facilities
• Probability-based prioritisation that categorises cases as high, intermediate, or low probability (example thresholds shown include 88%, 63%, and 33%) to support faster escalation of urgent cases
• Explainable visual outputs that highlight regions of interest using bounding boxes to show where suspected abnormalities appear

Available on Web.

Targeted at B2B healthcare providers, including radiologists and imaging teams in public hospitals, private practices, emergency rooms, ICUs, and point-of-care settings (including portable X-ray use cases and routine monitoring for patients with mild symptoms).

Notable in the African market context, the product is licensed by SAHPRA as a Class A Medical Device and has FDA 510(k) clearance for triaging Pneumothorax and Pleural Effusion, supporting deployment in regulated clinical environments, including high-burden TB regions such as South Africa.